BUVIDAL
LIVE

Serial Number

79236518

Owner

CAMURUS AB

Attorney

Karen Kreider Gaunt

Filing Date

May 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BUVIDAL Trademark

Serial Number: 79236518 • Registration: 5940519

BUVIDAL is a trademark filed by CAMURUS AB on May 28, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CAMURUS AB (33 trademarks)

JÄGERSHILLGATAN 15
MALMÖ SE-213 75 , SE

Entity Type: 03

Trademark Details

Filing Date

May 28, 2018

Registration Date

December 24, 2019

Published for Opposition

October 8, 2019

Goods & Services

Pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; veterinary pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; sanitary preparations for medical purposes; dietetic substances, namely dietetic beverages and dietetic sugar adapted for medical use, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; plasters for medical purposes, materials for dressings, namely, medical dressings, all for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; disinfectants; preparations for destroying vermin; fungicides, herbicides

Medical services; veterinary services; consultancy relating to medicines in the nature of providing medical consultancy services

Scientific and technological services and research, development and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicines, all for use in the fields of treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, treatment of opiate and chemical addictions, treatment of co-morbidities associated with substance use disorders, treatment of mental health diseases and disorders, treatment of central nervous system diseases and disorders, and management and relief of pain; chemical laboratories; chemical research, chemical analysis; research in the fields of medicines, foods, cosmetics and biotechnology; development of technical know-how, namely, technical advice, information, support and consultancy namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicine, all in the fields of the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, the treatment of opiate and chemical addictions, the treatment of co-morbidities associated with substance use disorders, the treatment of mental health diseases and disorders, the treatment of central nervous system diseases and disorders, and management and relief of pain

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 14, 2025 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 24, 2024 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 4, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 4, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 4, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 4, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 4, 2024 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 24, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2020 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 3, 2020 OPNX
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 18, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 4, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2019 NONP
ASSIGNED TO LIE
Sep 5, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 27, 2019 ERFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 26, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 26, 2019 REAP
FINAL REFUSAL MAILED
Apr 22, 2019 CNFR
FINAL REFUSAL WRITTEN
Apr 21, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2019 TROA
REFUSAL PROCESSED BY IB
Oct 12, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 18, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 17, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 17, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2018 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 12, 2018 SDRC